NCT06042400View on ClinicalTrials.gov

Trial of Written Exposure for Metastatic Cancer Patients (EASE)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

September 21, 2023

Study Completion Date

September 21, 2023

Conditions
Metastatic CancerSolid Tumor CancerLymphoproliferative DisordersAnxietyPost-traumatic Stress SymptomsFear of Cancer Progression
Interventions
BEHAVIORAL

Written Exposure Therapy

An innovative written exposure therapy intervention that addresses psychosocial needs commonly experienced by patients with late stage cancers.

Trial Locations (1)

80309

University of Colorado Boulder, Boulder

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

University of Colorado, Boulder

OTHER